深圳微芯生物科技股份有限公司

Group 1 - The core point of the announcement is the change in equity holdings of major shareholders, specifically that Bio-ao Biological Group Co., Ltd. and its concerted party Tianfu Qingyuan Holdings Co., Ltd. have reduced their shareholding in Micron Biotech from 10.00% to 8.82% [1][2] - The reduction involved a total of 4,829,464 shares sold through competitive and block trading from October 23, 2025, to November 19, 2025 [2] - The equity change does not trigger a mandatory tender offer and is part of a previously disclosed share reduction plan, which is still ongoing [2][3] Group 2 - The company’s board of directors has proposed to extend the validity period of the shareholder meeting resolution regarding the issuance of A-shares to specific targets for an additional 12 months, until December 5, 2026 [5][6] - This extension is intended to ensure the smooth progress of the issuance work, with all other aspects of the issuance plan remaining unchanged [6][29] - The board meeting that approved this proposal was held on November 19, 2025, with all eight attending directors voting in favor [27][30] Group 3 - The company will hold its first temporary shareholder meeting of 2025 on December 5, 2025, at 14:30, to discuss various proposals including the extension of the A-share issuance resolution [9][39] - The meeting will utilize both on-site and online voting methods, with specific timeframes for each voting method outlined [11][12] - Shareholders must register in advance to attend the meeting, with detailed registration procedures provided [21][22]